{"id":849,"date":"2017-07-28T11:56:44","date_gmt":"2017-07-28T10:56:44","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=849"},"modified":"2017-07-28T12:04:42","modified_gmt":"2017-07-28T11:04:42","slug":"diclo-sr-75-pain-relief-tablets-class-2-recall","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","title":{"rendered":"Class 2 recall for Diclo-SR 75 pain-relief tablets"},"content":{"rendered":"

A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75<\/em> pain relief tablets – AKA diclofenac sodium.<\/p>\n

The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a group of medicines called non-steroidal anti-inflammatory drugs.
\n<\/p>\n

Side-effects<\/h2>\n

Medicines commonly have side-effects, and the risk can be greater with higher doses and prolonged use of the medication.<\/p>\n

Strides Pharma U.K. Ltd (trading as Co-pharma) may have exacerbated the panic for some users, noting some batches of the medicines showed some high trending stability results in impurity tests.<\/p>\n

Affected batches<\/h3>\n

The affected batches are reportedly as follows:<\/p>\n

\n\n\n\n\n\n\n\n\n\n
Batch Number<\/th>\nExpiry Date<\/th>\nPack Size<\/th>\nFirst Distributed<\/th>\n<\/tr>\n<\/theader>\n
7226423<\/td>\n02.2019<\/td>\n28 tablets<\/td>\n07\/08\/2016<\/td>\n<\/tr>\n
7226424<\/td>\n02.2019<\/td>\n28 tablets<\/td>\n07\/08\/2016<\/td>\n<\/tr>\n
7226425<\/td>\n03.2019<\/td>\n28 tablets<\/td>\n07\/08\/2106<\/td>\n<\/tr>\n
7227697<\/td>\n06.2019<\/td>\n56 tablets<\/td>\n20\/10\/2016<\/td>\n<\/tr>\n
7227698<\/td>\n06.2019<\/td>\n56 tablets<\/td>\n20\/10\/2016<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Recall classes<\/h3>\n

Medicine recalls are often based on a tiered structure:<\/p>\n

\n